Fig. 2From: Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case reportTime-course result of patient remedy and effect, including thyroglobulin level. Alphabets in the figures (shown in red, such as (A)) correspond to the alphabets in Fig. 1Back to article page